enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Ubrogepant - Wikipedia

    en.wikipedia.org/wiki/Ubrogepant

    Ubrogepant, sold under the brand name Ubrelvy, is a medication used for the acute (immediate) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults. [4] [5] It is not indicated for the preventive treatment of migraine. [6] Ubrogepant is a small-molecule calcitonin gene-related peptide receptor antagonist.

  3. Semaglutide - Wikipedia

    en.wikipedia.org/wiki/Semaglutide

    [14] [15] [16] The most common side effects include nausea, vomiting, diarrhea, abdominal pain, and constipation. [14] [17] [18] [19] [29] It was approved for medical use in the US in 2017. [14] [30] In 2022, it was the 48th most commonly prescribed medication in the United States, with more than 13 million prescriptions. [31] [32]

  4. Dostarlimab - Wikipedia

    en.wikipedia.org/wiki/Dostarlimab

    Dostarlimab was approved for the treatment of endometrial cancer in both the United States and the European Union in April 2021. [5] [6] [11] [8] [12] Based on the Garnet trial, dostarlimab gained accelerated approval from the US Food and Drug Administration (FDA) in April 2021, [6] and full approval in February 2023. [7]

  5. Obecabtagene autoleucel - Wikipedia

    en.wikipedia.org/wiki/Obecabtagene_autoleucel

    Obecabtagene autoleucel, sold under the brand name Aucatzyl, is an anti-cancer medication used for the treatment of acute lymphoblastic leukemia. [ 1 ] [ 2 ] It is a CD19 -directed genetically modified autologous T-cell immunotherapy.

  6. Chemotherapy-induced nausea and vomiting - Wikipedia

    en.wikipedia.org/wiki/Chemotherapy-induced...

    Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. In 1983, Coates et al. found that patients receiving chemotherapy ranked nausea and vomiting as the first and second most severe side effects, respectively.

  7. AbbVie Scores US Antitrust Approval for $63B Allergan Deal - AOL

    www.aol.com/news/abbvie-scores-us-antitrust...

    “It brings in additional growth drivers at an attractive price, including products early in their life cycle (e.g. Vraylar, Ubrelvy) and others that should be highly durable (e.g. Botox ...

  8. J&J's chemotherapy-free treatment for lung cancer gets US ...

    www.aol.com/news/us-fda-approves-j-js-111733970.html

    The approval allows the use of the cancer drug, Rybrevant, in combination with J&J's existing drug, lazertinib, as a first-line treatment for non-small cell lung cancer (NSCLC) patients with a ...

  9. Eribulin - Wikipedia

    en.wikipedia.org/wiki/Eribulin

    Eribulin, sold under the brand name Halaven among others, is an anti-cancer medication used to treat breast cancer and liposarcoma. [4] [5]The most common side effects include fatigue, nausea, hair loss (alopecia), constipation, certain nerve damage causing weakness or numbness in the hands and feet (peripheral neuropathy), abdominal pain and fever (pyrexia). [10]

  1. Related searches how to get ubrelvy approved for cancer medications side effects in women

    ubrelvy for migrainesubrelvy wikipedia